Centene (NYSE:CNC) Shares Gap Down – Here’s Why

Centene Corporation (NYSE:CNCGet Free Report)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $64.08, but opened at $59.51. Centene shares last traded at $58.2790, with a volume of 2,347,382 shares traded.

More Centene News

Here are the key news stories impacting Centene this week:

  • Positive Sentiment: Centene reported second-quarter adjusted earnings of $2.51 per share, well above analyst expectations, while revenue reached $53.58 billion, up 9.9% year over year. Improved medical cost management and stronger performance across Medicare, Medicaid and Marketplace businesses helped the insurer return to profitability. Centene Finds Profit Growth Even as Medicaid Membership Softens
  • Positive Sentiment: Management raised its 2026 earnings outlook to approximately $4.80 per share, citing better cost discipline, margin recovery and favorable premium trends. The outlook increase supports the case that Centene’s earnings recovery is gaining traction. Centene Lifts 2026 Outlook as Insurer Contains Medical Costs
  • Positive Sentiment: Centene’s announced redemption of $500 million of its 4.25% 2027 notes indicates active balance-sheet management and could reduce future interest expense. Centene Announces Partial Redemption of 2027 Notes
  • Neutral Sentiment: Robert W. Baird raised its price target from $46 to $66 but maintained a neutral rating, suggesting analysts see limited near-term upside after CNC’s substantial recovery. Benzinga
  • Negative Sentiment: The key concern is declining Medicaid membership, partly linked to eligibility redeterminations, which could pressure revenue growth and raise questions about the durability of the turnaround. Coverage also highlighted Medicaid-related uncertainty despite the earnings beat. Oscar Health Flashes Buy Signal As Medicaid Weighs On Centene
  • Negative Sentiment: Investors may also be taking profits after CNC’s roughly 150% run, particularly because membership declines remain unresolved and the stock trades above its 50-day moving average. Centene Stock Still Looks Like a Bargain As Its 150% Run Continues

Analysts Set New Price Targets

A number of brokerages have weighed in on CNC. Robert W. Baird upped their price objective on shares of Centene from $46.00 to $66.00 and gave the stock a “neutral” rating in a report on Wednesday. Barclays reiterated an “overweight” rating and set a $80.00 target price (up from $75.00) on shares of Centene in a report on Wednesday. Weiss Ratings restated a “sell (d)” rating on shares of Centene in a research note on Friday, July 17th. Deutsche Bank Aktiengesellschaft raised Centene from a “hold” rating to a “buy” rating and raised their price objective for the company from $53.00 to $80.00 in a research report on Wednesday, May 20th. Finally, Mizuho set a $63.00 target price on Centene and gave the stock a “neutral” rating in a report on Monday, June 8th. Seven investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $67.00.

Get Our Latest Analysis on Centene

Centene Price Performance

The firm’s fifty day simple moving average is $63.74 and its 200-day simple moving average is $50.09. The firm has a market capitalization of $30.51 billion, a PE ratio of -5.92, a PEG ratio of 0.36 and a beta of 1.07. The company has a quick ratio of 1.12, a current ratio of 1.15 and a debt-to-equity ratio of 0.71.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $2.51 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $1.42. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The firm had revenue of $53.58 billion for the quarter, compared to analysts’ expectations of $47.64 billion. During the same quarter in the prior year, the company posted ($0.16) earnings per share. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 4.800- EPS. On average, research analysts forecast that Centene Corporation will post 4.8 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Baird Financial Group Inc. purchased a new position in Centene in the 1st quarter worth about $236,000. Sivia Capital Partners LLC boosted its holdings in shares of Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after acquiring an additional 4,315 shares during the last quarter. CW Advisors LLC grew its stake in shares of Centene by 20.3% in the second quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after acquiring an additional 820 shares during the period. NewEdge Advisors LLC grew its stake in shares of Centene by 6.1% in the second quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after acquiring an additional 2,582 shares during the period. Finally, Treasurer of the State of North Carolina raised its holdings in shares of Centene by 0.4% during the second quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock valued at $12,590,000 after purchasing an additional 967 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Company Profile

(Get Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Further Reading

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.